Ye-fa Yang
Shanghai, 200438, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Portal vein embolization for arterio-portal shunt closure in hepatocellular carcinoma to facilitate selective internal radiation therapy.
Journal: World journal of radiology
Published: April 07, 2026
Coil-assisted N-butyl cyanoacrylate embolization vs covered stent implantation for delayed hemorrhage in hepatobiliary and pancreatic surgery.
Journal: World journal of gastrointestinal surgery
Published: May 06, 2025
Portal vein embolization for closure of marked arterioportal shunt of hepatocellular carcinoma to enable radioembolization: A case report.
Journal: World journal of gastrointestinal surgery
Published: August 17, 2023
Endovascular treatment of delayed arterial hemorrhage after radical operation for hilar cholangiocarcinoma.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: July 30, 2022
Recurrent undifferentiated embryonal sarcoma of the liver in adult patient treated by pembrolizumab: A case report.
Journal: World journal of clinical cases
Published: September 20, 2020
Associating liver partition and portal vein ligation for staged hepatectomy versus sequential transarterial chemoembolization and portal vein embolization in staged hepatectomy for HBV-related hepatocellular carcinoma: a randomized comparative study.
Journal: Hepatobiliary surgery and nutrition
Published: January 30, 2020
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition).
Journal: Liver cancer
Published: January 03, 2018
Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging.
Journal: Radiology
Published: April 15, 2016
Evolving Role of Radiopharmaceuticals in Hepatocellular Carcinoma Treatment.
Journal: Anti-cancer agents in medicinal chemistry
Published: September 27, 2015
Genetic Variants in ASCT2 Gene are Associated with the Prognosis of Transarterial Chemoembolisation-Treated Early- Stage Hepatocelluar Carcinoma.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: May 20, 2015
Loss of FOXF2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients.
Journal: Annals of surgical oncology
Published: November 27, 2014
Leukocyte telomere length predicts overall survival in hepatocellular carcinoma treated with transarterial chemoembolization.
Journal: Carcinogenesis
Published: February 10, 2012
Last Updated: 09/26/2026